Ekso Bionics Ownership
| EKSO Stock | USD 0.63 0.01 1.56% |
Shares in Circulation | First Issued 2012-06-30 | Previous Quarter 18.2 M | Current Value 20.3 M | Avarage Shares Outstanding 6 M | Quarterly Volatility 5.9 M |
Ekso |
Ekso Stock Ownership Analysis
About 25.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.94. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ekso Bionics Holdings recorded a loss per share of 0.64. The entity last dividend was issued on the 25th of March 2020. The firm had 1:15 split on the 25th of March 2020. Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company was incorporated in 2005 and is headquartered in Richmond, California. Ekso Bionics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 55 people. To learn more about Ekso Bionics Holdings call the company at 510 984 1761 or check out https://www.eksobionics.com.Besides selling stocks to institutional investors, Ekso Bionics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Ekso Bionics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Ekso Bionics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Ekso Bionics Quarterly Liabilities And Stockholders Equity |
|
About 8.0% of Ekso Bionics Holdings are currently held by insiders. Unlike Ekso Bionics' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Ekso Bionics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Ekso Bionics' insider trades
Ekso Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Ekso Bionics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ekso Bionics Holdings backward and forwards among themselves. Ekso Bionics' institutional investor refers to the entity that pools money to purchase Ekso Bionics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Xtx Topco Ltd | 2024-09-30 | 11.1 K | Advisor Group Holdings, Inc. | 2024-09-30 | 3.1 K | Tower Research Capital Llc | 2024-09-30 | 1.1 K | Harbour Investments, Inc. | 2024-09-30 | 458 | Tradewinds Capital Management, Llc | 2024-09-30 | 260 | Bank Of America Corp | 2024-09-30 | 246 | Goss Wealth Management Llc | 2024-09-30 | 200 | Ubs Group Ag | 2024-09-30 | 148 | Hanson Mcclain Inc | 2024-09-30 | 64.0 | Armistice Capital, Llc | 2024-09-30 | 2.2 M | Kent Lake Capital Llc | 2024-06-30 | 696 K |
Ekso Bionics Holdings Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ekso Bionics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ekso Bionics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ekso Bionics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ekso Bionics Outstanding Bonds
Ekso Bionics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ekso Bionics Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ekso bonds can be classified according to their maturity, which is the date when Ekso Bionics Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Pair Trading with Ekso Bionics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.Moving against Ekso Stock
| 0.85 | LNSR | LENSAR Inc | PairCorr |
| 0.81 | HSTM | HealthStream | PairCorr |
| 0.68 | HQY | HealthEquity | PairCorr |
| 0.67 | CAH | Cardinal Health Earnings Call This Week | PairCorr |
| 0.64 | HIMS | Hims Hers Health Aggressive Push | PairCorr |
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share | Quarterly Revenue Growth (0.10) | Return On Assets | Return On Equity |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.